Home / Stocks / DTIL

DTIL insider trading

PRECISION BIOSCIENCES INC — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
15
Bought · 24 mo
$210k
Buys · last 90 days
0 · $0
Most recent buy
2025-12-17

Cluster buy detected

4 insiders bought DTIL within a short window (2024-12-26→2024-12-30), $61k in total — cluster score 66/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-12-17Brown Melindacluster
Director
Bought1,381$4.97$7k
2025-12-17Germano Geno Jcluster
Director
Bought3,000$4.72$14k
2025-12-17Frankel Stanleycluster
Director
Bought2,700$4.70$13k
2025-09-30Frankel Stanley
Director
Bought2,700$4.97$13k
2025-09-24Brown Melinda
Director
Bought1,400$4.89$7k
2025-06-27Brown Melinda
Director
Bought1,682$4.14$7k
2025-06-27Buehler Kevin
Director
Bought5,076$4.16$21k
2025-03-28Brown Melindacluster
Director
Bought1,839$4.75$9k
2025-03-28Buehler Kevincluster
Director
Bought4,523$4.67$21k
2025-03-27Germano Geno Jcluster
Director
Bought3,250$5.30$17k
2025-01-02Germano Geno Jcluster
Director
Bought3,605$4.49$16k
2024-12-31Buehler Kevincluster
Director
Bought4,320$4.88$21k
2024-12-31Kelly John Alexandercluster
Chief Financial Officer
Bought2,113$4.75$10k
2024-12-30Brown Melindacluster
Director
Bought3,016$4.55$14k
2024-11-21Kelly John Alexander
Chief Financial Officer
Bought3,000$6.76$20k

Most active insider buyers

InsiderRoleBuysTotal bought
Buehler KevinDirector3$63k
Germano Geno JDirector3$48k
Brown MelindaDirector5$43k
Kelly John AlexanderChief Financial Officer2$30k
Frankel StanleyDirector2$26k

See DTIL on the chart

Every insider buy and sell for DTIL plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.